The relentless progression of neurodegenerative diseases, such as Parkinson's disease, necessitates a shift in therapeutic strategies, moving beyond symptomatic control towards disease-modifying therapies. Recent advances in genomics have illuminated several potential novel targets. These include

The field of biomedical drug delivery is continuously evolving, with a focus on enhancing the efficacy and tolerability of therapeutic agents. Drug delivery technologies are designed to administer drugs in a targeted and controlled manner, minimizing side effects and maximizing therapeutic outcom